Home > List All Publishers > Global Markets Direct

Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Reports
Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning. These reports include in-depth company reports such as Company Market Share reports, which give a detailed breakdown of revenues by market and region, and Company Asset Reports, which give details of companies’ key assets by geography.

Company Strategic Analysis Reports include in-depth value chain and SWOT analysis, while Company Financial Deal Profiles highlight key financial deals that have shaped the company. Global Markets Direct also produces a wide range of market reports giving access to high value unique databases of information, examples include historic and forecast asset reports and market share reports covering value, volume, distribution and company shares.

Sectors and Geographies Covered
Global Markets Direct specializes in the Energy and Medical Equipment Markets. It has a global scope, covering a broad range of countries constituting more than 90% of global revenues in each of the industries it covers.

Research Methodology
With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.

List of reports from Global Markets Direct

Paralysis – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Paralysis. Paralysis - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Metastatic Adenocarcinoma of The Pancreas – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... provides information on the therapeutic development for Metastatic Adenocarcinoma of The Pancreas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ... \| read more...	$2,000.00
Relapsing Multiple Sclerosis (RMS) – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... on the therapeutic development for Relapsing Multiple Sclerosis (RMS), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Relapsing Multiple Sclerosis ... \| read more...	$2,000.00
Enterococcus Infections – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Enterococcus Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Enterococcus Infections. Enterococcus Infections - Pipeline Review, Half Year ... \| read more...	$2,000.00
Hyperglycemia – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hyperglycemia. Hyperglycemia - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Keloids – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Keloids. Keloids - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Infantile Hemangiomas – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Infantile Hemangiomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Infantile Hemangiomas. Infantile Hemangiomas - Pipeline Review, Half Year ... \| read more...	$2,000.00
Influenza A And B Infections – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... provides information on the therapeutic development for Influenza A And B Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ... \| read more...	$2,000.00
Male Sexual Dysfunction – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... therapeutic development for Male Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Male Sexual Dysfunction. Male Sexual Dysfunction ... \| read more...	$2,000.00
Meningococcal Meningitis – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Meningococcal Meningitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Meningococcal Meningitis. Meningococcal Meningitis - Pipeline Review, Half Year ... \| read more...	$2,000.00
Essential Tremor – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... for Essential Tremor, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Essential Tremor. Essential Tremor - Pipeline Review, Half Year ... \| read more...	$2,000.00
Sedation – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sedation. Sedation - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Xerosis (Dry Skin) – Pipeline Review, H1 2013 4/30/2013 \| published by: Global Markets Direct ... therapeutic development for Xerosis (Dry Skin), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Xerosis (Dry Skin). Xerosis (Dry Skin) ... \| read more...	$2,000.00
Eli Lilly and Company – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets ... \| read more...	$1,500.00
Genentech, Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Genentech, Inc.’s corporate ... \| read more...	$1,500.00
Astellas Pharma Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ... \| read more...	$1,500.00
Eisai Co., Ltd. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ... \| read more...	$1,500.00
MedImmune, LLC – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, MedImmune, LLC’s corporate ... \| read more...	$1,500.00
Daiichi Sankyo Company, Limited – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets ... \| read more...	$1,500.00
Celgene Corporation – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Celgene Corporation’s corporate ... \| read more...	$1,500.00
Merck KGaA – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Merck KGaA’s corporate ... \| read more...	$1,500.00
Yuhan Corporation – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Yuhan Corporation’s corporate ... \| read more...	$1,500.00
Addex Therapeutics – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Addex Therapeutics’s corporate ... \| read more...	$1,500.00
Alnylam Pharmaceuticals, Inc. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ... \| read more...	$1,500.00
Daewoong Pharmaceutical Co., Ltd. – Product Pipeline Review – 2013 4/30/2013 \| published by: Global Markets Direct ... research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets ... \| read more...	$1,500.00

< prev 1 2 3 4 5 6 7 8 9 10 next >